Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416191 · ClinicalTrials.gov registry record · NA
Immune Cells During Disuse and Recovery
A NA study of Muscle Disuse, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT04416191 is a NA study of Muscle Disuse that is actively recruiting participants, run by University of Utah. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04416191, a NA study of Muscle Disuse, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an interventional study enrolling healthy individuals aged 18-35 and 60-85 to understand the recovery of muscle health following a period of inactivity. The enrollment goal is 45 participants. The study will occur over the course of 1-2 months where participants will undergo testing before and after a 2-week limb immobilization period.
Conditions Studied
Interventions
- OTHER Limb immobilization
Study Locations (1)
Utah
- The University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-05-15 |
| Est. Completion | 2028-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04416191
The ClinicalTrials.gov registry entry for NCT04416191 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Muscle Disuse appearing as the primary indexed condition, and to 1 intervention - of which Limb immobilization is the first listed.
NCT04416191 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT04416191 about?
NCT04416191 is a clinical study titled "Immune Cells During Disuse and Recovery". This is an interventional study enrolling healthy individuals aged 18-35 and 60-85 to understand the recovery of muscle health following a period of inactivity. The enrollment goal is 45 participants. The study will occur over the course of 1-2 months where participants will undergo testing before a...
What is the current status of trial NCT04416191?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2022-05-15. Estimated completion is 2028-04-30.
What conditions does trial NCT04416191 study?
This clinical trial studies the following conditions: Muscle Disuse.
What interventions are being tested in trial NCT04416191?
The interventions under investigation include: Limb immobilization (OTHER).
Who is sponsoring clinical trial NCT04416191?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04416191 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Disuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.